Free radical-mediated oxidative damage to proteins, lipids, and DNA occurs in neurons during acute brain injuries and in neurodegenerative disorders. Membrane lipid peroxidation contributes to neuronal dysfunction and death, in part by disrupting neuronal ion homeostasis and cellular bioenergetics. Emerging findings suggest that 4-hydroxynonenal (HNE), an aldehyde produced during lipid peroxidation, impairs the function of various proteins involved in neuronal homeostasis. Here we tested the hypothesis that HNE impairs the cellular system that removes damaged proteins and organelles, the autophagy-lysosome pathway in rat primary cortical neurons. We found that HNE, at a concentration that causes apoptosis over a 48-72 h period, increases protein levels of LC3 II and p62 and within 1 and 4 h of exposure, respectively; LC3 II and p62 immunoreactive puncta were observed in the cytoplasm of HNE-treated neurons at 6 h. The extent of up-regulation of p62 and LC3 II in response to HNE was not affected by cotreatment with the lysosome inhibitor bafilomycin A1, suggesting that the effects of HNE on autophagy were secondary to lysosome inhibition. Indeed, we found that neurons exposed to HNE exhibit elevated pH levels, and decreased protein substrate hydrolysis and cathepsin B activity. Neurons exposed to HNE also exhibited the accumulation of K63-linked polyubiquitinated proteins, which are substrates targeted for lysosomal degradation. Moreover, we found that the levels of LAMP2a and constitutively active heat-shock protein 70, and numbers of LAMP2a-positive lysosomes, are decreased in neurons exposed to HNE. Our findings demonstrate that the lipid peroxidation product HNE causes early impairment of lysosomes which may contribute to the accumulation of damaged and dysfunctional proteins and organelles and consequent neuronal death. Because impaired lysosome function is increasingly recognized as an early event in the neuronal death that occurs in neurodegenerative disorders, our findings suggest a role for HNE in such lysosomal dysfunction.
susceptible to lipid peroxidation, an autocatalytic process that generates the potentially cytotoxic aldehyde 4-hydroxynonenal (HNE). HNE is an amphipathic molecule that can covalently modify cysteine, lysine, and histidine residues of proteins in many subcellular compartments, including the cytosol, mitochondria, and nucleus (Uchida 2003; Mattson 2009 ). Glutathione, a tripeptide with a cysteine residue binds and thereby detoxifies HNE (Kruman et al. 1997; Perluigi et al. 2012) . In the brains of AD and PD patients, and in experimental models relevant to these neurodegenerative disorders, HNE accumulates in brain cells in concentrations of 1-100 lM (Lovell et al. 1997; Mark et al. 1997a,b; Markesbery and Lovell 1998; Perluigi et al. 2012) . HNE can trigger the aggregation of proteins involved in the pathogenesis of AD and PD including amyloid b-peptide (Ab) and a-synuclein (Chen et al. 2006; Plotegher and Bubacco 2016) . In addition, HNE can cause synaptic dysfunction and neuronal death in cell culture and animal models relevant to AD and PD Kruman et al. 1997; Mark et al. 1997a,b) . HNE-protein adducts are detected in inclusions of vulnerable brain regions in PD (Yoritaka et al. 1996) , Lewy body dementia (Dalfo et al. 2005) , AD (Butterfield et al. 2001; Reed et al. 2009; Hardas et al. 2013) and Down syndrome (Di Domenico et al. 2014) , and in spinal cord motor neurons in ALS (amyotrophic lateral sclerosis) patients (Pedersen et al. 1998; Kabuta et al. 2015) .
Autophagy is a process in which damaged/aggregating proteins are transferred to lysosomes wherein they are degraded (Klionsky et al. 2016) . Recent findings suggest that the autophagy-lysosome pathway is impaired in AD and PD (reviewed by Nixon 2013) . Neurons may be particularly prone to impaired lysosomal degradation of autophagic substrates because of their large size, high rates of metabolism, and generation of reactive oxygen species, and in contrast to mitotic cells, post-mitotic neurons are unable to segregate and dilute substrates during cell division. Vulnerable neurons in AD exhibit the accumulation of autophagic vesicles and autolysosomes in neuritic swellings, and inhibition of lysosome function can cause similar neuritic pathology in wild-type mice and can exacerbate autophagic pathology in mouse models of AD (Nixon and Yang 2011) . Mutations in presenilin 1 that cause autosomal dominant early-onset AD impair lysosome function, apparently by compromising a normal function of presenilin 1 in promoting lysosomal acidification (Lee et al. 2010) . Accumulation of markers of macroautophagy, including microtubule-associated protein 1A/1B light chain 3 (LC3) II and p62 are increased in association with neuronal degeneration in AD (Kuusisto et al., 2001) . On the other hand, markers of chaperone-mediated autophagy (CMA) including LAMP2a and constitutively active heatshock protein 70 (Hsc70), which involves targeting of ubiquitinated proteins to the lysosomes, are reduced in affected neurons in PD (Alvarez-Erviti et al. 2010) .
Emerging evidence suggests that HNE can alter the autophagy -lysosome pathway. Tumor cells and smooth muscle cells exposed to HNE exhibit increased levels of LC3 II in differentiated SH-SY5Y neuroblastoma cells and aortic smooth muscle cells (Hill et al. 2008; Dodson et al. 2013) . The removal of HNE-protein adducts is accelerated by the autophagy inducer, rapamycin, and decreased by the autophagy inhibitor 3-methyladenine (3-MA) (Hill et al. 2008) . HNE-modified photoreceptor outer segments inhibit autophagy and enhance lipofuscinogenesis in human retinal pigment epithelium, which is associated with inhibition of the lysosomal enzymes cathepsin B and cathepsin L (Krohne et al. 2010) . However, very little is known about the role of HNE on autophagy and lysosomal function in neurons. Here we report that HNE interferes in both macroautophagy and the CMA pathway by inhibiting lysosome function, which can trigger neuronal apoptosis.
Materials and methods

Reagents
All reagents were obtained from Sigma (St. Louis, MO, USA) unless otherwise specified. LysoSensor and SYBR Green PCR Master Mix were purchased from Life Technologies Inc. (Grand Island, NY, USA). HNE and bafilomycin A1 (Baf) was from Cayman Chemical Company (Ann Arbor, MI, USA). Rapamycin and wortmannin were purchased from Sigma Chemical Company. Fluorescence-quenched bovine serum albumin conjugate (DQ-BSA) was from Thermo Fisher Scientific (Waltham, MA, USA). Anti-HNE antibody was from Alpha Diagnostic (catalog #HNE13-M; San Antonio, TX, USA). Cathepsin B and cathepsin D activity assay kits, anti-SQSTM1/p62, anti-LAMP2a (catalog #ab18528), and anti-cathepsin B (catalog #ab58802) antibodies were from Abcam (Cambridge, MA, USA). Anti-cleaved caspase-3 (catalog #9661)) and anti-cathepsin D (catalog # 2284) antibodies were from Cell Signaling Technology (Danvers, MA, USA). Anti-LC3 (catalog #NB100-2220), and Anti-Hsc70 (catalog #NB120-2788) antibodies were from Novus Biologicals (Littleton, CO, USA). Anti mono-and polyubiquitinylated conjugated antibody was from Enzo Life Sciences (catalog #PW8810; Farmingdale, NY, USA). Anti K48-linked and K63-linked polyubiquitin antibodies (catalog number 05-1307 and 05-1308, respectively) were from EMD Millipore (Billerica, MA, USA). 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay kit was from Promega Life Sciences (Madison, WI, USA). Lactate dehydrogenase (LDH) assay kit was from Roche Diagnostics (Indianapolis, IN, USA).
Primary neuronal culture
Cultures of primary cortical neurons were prepared from embryonic day 18 (E18) Sprague-Dawley rats (purchased from Charles River Laboratories, Raleigh, NC, USA). All animal procedures were approved by the animal care and use committee of the National Institute on Aging Intramural Research Program, and complied with NIH guidelines. Dissociated cells were plated onto polyethyleneimine-coated plastic dishes or glass coverslips in MEM medium (Invitrogen Inc., Carlsbad, CA, USA) supplemented with 10% Hyclone III (Thermo Fisher Scientific) at a density of 3.0 9 10 5 cells/cm 2 for biochemistry and 1.0 9 10 4 cells/cm 2 for immunocytochemistry analysis. After cells attached to the surface (4 h), the medium was changed to Neurobasal medium containing B27 supplements (Invitrogen). Every 7 days, 50% of the medium volume was removed and replaced with fresh medium. Immediately prior to experimental treatment, the culture medium was replaced with fresh Neurobasal medium. HNE and bafilomycin were prepared as 20009 stocks in ethanol and dimethylsulfoxide, respectively. Control cultures were exposed to ethanol and/or dimethylsulfoxide in the same amounts as the cultures exposed to HNE and/or bafilomycin.
Cell viability assays
The MTS assay (Promega Corporation, Madison, WI, USA) and LDH assay (Roche Life Science, Indianapolis, IN, USA) were performed according to the manufacturer's instructions. Neurons were grown in 96-well plates at a density of 10 000 cells/well for 7 days. Different concentrations of HNE were then added to the culture medium for indicated hours. The culture medium was removed for the LDH assay and cells were left in wells for the MTS assay. The absorbance (optical density) value was read at a wavelength of 492 nm with a microplate reader (Biotek, Winooski, VT, USA).
Cell fractionation and immunoblot analysis
For extraction of protein for immunobloting of LC3, p62, b-actin, LAMP2a, Hsc70, CathepsinB and D, the neurons were harvested, washed twice with ice-cold phosphate-buffered saline (PBS), and lysed with radioimmunoprecipitation assay lysis buffer [50 mM Tris, pH 7.4, 150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), 1% NP-40, 2 mM EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 200 lM Na 3 VO 4 , 50 mM NaF and protease inhibitors (Roche)] on ice for 20 min, and centrifuged at 15 600 g for 15 min. For extraction of protein for immunobloting of HNE and ubiquitin-modified proteins, the method was adopted from Choo and Zhang (2009) . Neurons were lysed in 2% SDS lysis buffer [50 mM Tris-HCl, pH 7.6, 1.0% Triton X-100, 2% SDS, 10 lg/mL aprotinin, 5 mM NaF, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 1 mM Na 3 VO 4 , and protease inhibitors (Roche)], boiled at 100°C for 10 min, and then centrifuged at 20 000 g for 15 min. The protein concentration of the supernatant was determined using a bicinchoninic acid protein assay kit (Thermo Fisher Scientific). Samples were heated to 70°C in NuPAGE LDS sample buffer (Invitrogen) and loaded onto NuPAGE Bis-Tris gels (Invitrogen) for protein separation. Following electrophoresis, proteins were transferred from the gel to a nitrocellulose sheet by electrophoresis and the sheet was stained with Ponceau S solution (Sigma) to briefly assess the efficiency of transfer. Then, the sheet was washed with deionized water and incubated overnight at 4°C with a primary antibody which included: anti-actin (A2066; Sigma), Immunofluorescence and confocal microscopy Cortical neurons were grown on glass coverslips for 7 days with or without specific treatments before immunostaining. For immunostaining of cleaved caspase 3 and ubiquitin, neurons were washed in PBS twice and then fixed in PBS containing 4% paraformaldehyde for 20 min at 23°C. Cell membranes were then permeabilized by incubation in 0.2% Triton X-100 in PBS for 30 min. For immunostaining of LC3 and p62, neurons were washed in PBS twice and then fixed in 100% methanol for 15 min at À20°C. After fixation, neurons were incubated in 3% bovine serum albumin in PBS for 1 h, and then incubated with a primary antibody diluted in blocking buffer overnight at 4°C. Primary antibodies included those against: cleaved caspase-3 (# 9661; Cell Signaling Technology), LC3 (NB100-2220; Novus Biologicals), SQSTM1/p62 (ab56416; Abcam), and mono-and poly-ubiquitinylated conjugates (BML-PW8810; Enzo Life Sciences). Alexa Fluor 488 and 568 (Invitrogen) were used as secondary antibodies. Cell nuclei were stained with Hoechst 33258 dye. Coverslips were mounted in Mountant Permafluor medium (Thermo Fisher Scientific) and visualized using a Zeiss LSM410 confocal microscope (Jena, Germany) with a 409 objective lens. Images were analyzed with Image J software.
Lysosensor staining and quantification of pixel intensities After the indicated treatments, cultured cortical neurons were incubated for 5 min in culture medium containing 1 lM LysoSensor-Green DND-189 (Invitrogen). The cells were then washed with fresh medium and observed and photographed using an Olympus IX50 fluorescence microscope (Waltham, MA, USA) with a 409 objective. The fluorescence intensity within the cell body of 60 neurons per group was quantified from images using Image J software, and data were analyzed using GraphPad Prism 5 software; GraphPad Software Inc., San Diego, CA, USA.
DQ TM Red BSA assay After 6 h of treatment with test agents, neurons were incubated with 10 lg/mL of BSA-DQ for an additional 1 h and then washed twice with fresh culture medium. The florescence intensity was measured using a plate reader with excitation at 578 nm and emission at 603 nm.
Cathepsin B and D activity assays
The assays were performed according to manufacturer's instructions. After treatments, neurons were washed twice in cold PBS, and then lysed in chilled cell lysis buffer. After incubation on ice for 20 min, the cell lysates were centrifuged at 4°C at 15 600 g for 5 min to remove any insoluble materials. A 50 lL aliquot of the supernatant was added to a well of a 96-well plate; 50 lL Cell Lysis Buffer was used as a control for background fluorescence. Next, 50 lL Cathepsin Reaction Buffer was added to each well, followed by 2 lL of 10 mM Cathepsin substrate. All reagents were mixed well and incubated at 37°C for 1 h before fluorescence was measured in a fluorescence plate reader using an excitation wavelength of 400 nm and emission at 505 nm. Relative fluorescence units were normalized to the total protein concentration used in the assay.
RNA isolation, RT-PCR, and real-time PCR Total RNA was isolated with Trizol RNA isolation reagent (Invitrogen), reverse transcribed to first-strand cDNA with SuperScript â III First-Strand Synthesis System (Invitrogen). For measuring the mRNA level of p62 and LC3, 20 lL reaction solutions were prepared in wells of a 96-well plate using TaqMan Fast Universal PCR Master Mix (29) (Cat # 4367846; Applied Biosystems, Foster City, CA, USA), cDNA template and Taqman primer probes included Gapdh (Rn01775763_g1), LC3B (Rn02132764_s1) and p62 (Rn00709977_m1). Quantitative polymerase chain reaction (Q-PCR) was carried out with StepOnePlus Real-Time PCR System. For measuring the mRNA level of LAMP2a and Hsc70, cDNA templates were amplified with SYBR Green PCR Master Mix (Invitrogen). The primers were (5 0 -3 0 ): ratHsc70 forward: CAGAATCCCCAAGATCCAGA; rat-Hsc70 reverse: GTGACATCCAAGAGCAGCAA; rat-actin forward; AAGGACTCCTATAGTGGGTGACGA; rat-actin-reverse: ATCT TCTCCATGTCGTCCCAGTTG; rat-Lamp2a-forward: GTCTCAA GCGCCATCATACT; rat-Lamp2a-reverse: TCCAAGGAGTCTGT CTTAAGTAGC. All procedures were performed according to the manufacturer's instructions. The transcription level of each gene was normalized with respect to those of Gapdh or b-actin.
Statistics
All data are presented as mean AE SEM. Comparisons between control and treatment groups were performed by using Student's unpaired t-test or analysis of variance where appropriate. Values of p < 0.05 were considered to be statistically significant.
Results
HNE induces relatively slow degeneration of cerebral cortical neurons
To test the effects of HNE on neurons, primary rat cortical neurons were grown for 7 days in culture before experiments were initiated. In a preliminary experiment, we found that HNE concentrations of 10 lM or greater were acutely toxic, killing the neurons within 12 h (data not shown). Using an MTS assay, we found that exposure of neurons to 5 lM HNE resulted in slow neuronal death, with no significant change in the level of MTS reduction at 12 or 24 h, but a highly significant decrease in MTS reduction levels at 48 h (66.6 AE 3.2%) and a further decrease by 72 h (57.7 AE 4.0%) (Fig. 1a) . Because a decrease in MTS reduction could result from impaired mitochondrial function without cell death, we measured levels of LDH activity in the culture medium of neurons treated with HNE or vehicle for increasing time points. LDH levels in the cultured medium were relatively low at all time points examined (5-10% of the total amount of LDH in the cell population). However, there was a significant doubling in the amount of LDH in the medium of neurons exposed to HNE for 24, 48, or 72 h compared to control cultures (Fig. 1a) . Because it was previously reported that HNE can trigger neuronal apoptosis (Kruman et al. 1997) , we performed two assays to evaluate apoptosis, namely quantifying cells with condensed and fragmented nuclear DNA (Hoechst staining), and measuring relative levels of cleaved caspase 3 immunoreactivity. With each of the latter methods, we found upwards of 60% of neurons exhibiting features of apoptosis in cultures treated with HNE for 48 h, compared to 5-10% of the neurons exhibiting these signs of apoptosis in control cultures ( Fig. 1c-e) . Given that the levels of MTS reduction were maintained through 24 h of exposure to HNE, and then dropped between the 24 and 48 h time points (Fig. 1a) , the data in Fig. 1(c) -(e) suggest that HNE primarily triggers apoptosis that occurs between 24 and 48 h of exposure. To determine whether HNE bound to proteins in the neurons, we exposed the neurons to 5 lM HNE or 0.05% ethanol (vehicle control) for 4 h, harvested the neurons in lysis buffer and performed immunoblot analysis on the samples using an antibody against HNE-protein adducts. As expected, there were much more HNE adducts in HNEtreated neurons, especially at higher molecular weights (Fig. 1b) .
Evidence that HNE causes the accumulation of autophagosomes in neurons
To investigate whether the autophagy pathway is altered in neurons exposed to HNE, cortical neurons were treated with 0.05% ethanol (Con) for 24 h or with 5 lM HNE for 1, 2, 4, 6, or 24 h. As a positive control, neuronal cultures were treated with 100 nM bafilomycin A1 (Baf) with or without HNE for 6 h. Bafilomycin A1 is a vacuolar ATPase inhibitor that elevates lysosomal pH and impairs fusion of autophagosomes with lysosomes, and increases the accumulation of the autophagosome-associated proteins LC3II and p62. LC3II levels increased gradually in neurons during the first 6 h of exposure to HNE (115.1 AE 4.1%, 124.9 AE 5.3%, 129.2 AE 5.7%, 146.3 + 5.3% at 1, 2, 4, and 6 h, respectively), then decreased at 24 h (129.8 AE 4.4%) ( Fig. 2a and  b) . The increase of LC3II in HNE-treated neurons at 6 h was comparable to that of neurons exposed to 100 nM Baf alone (136.0%) or co-treated with HNE (134.4%) for 6 h. Levels of p62 levels also increased in HNE-treated neurons during the first 6 h of exposure and then decreased by 24 h (Fig. 2c) . Baf treatment resulted in a significant elevation of p62 levels (175.5 AE 9.8%) at 6 h, and combined treatment with HNE and Baf (169.9 AE 6.8%) resulted in an elevation of p62 levels similar to that of Baf alone ( Fig. 2a and c) . To support the hypothesis that HNE inhibits lysosomal function, we inhibited the mTOR pathway with rapamycin to stimulate autophagy. Rapamycin (100 nM) alone significantly increased levels of LC3II and p62 in the neurons, and either modestly enhanced or had no effect on HNE-and bafilomycin-induced increases in levels of LC3II and p62 ( Fig. 2d-f ). Because levels of LC3II and p62 in neurons were greatest at the 6 h time point, we next evaluated the subcellular distribution of LC3 and p62 in neurons at that time point. Control neurons exhibited a diffuse distribution of LC3 and p62 with a few puncta in the cell body (Fig. 3a, upper  panels) . HNE-treated neurons exhibited numerous LC3 and p62 co-immunoreactive puncta in the cell body. (Fig. 3a  lower panels) . The number of LC3 and p62 puncta was counted in 182 control-neurons and 51 HNE-treated neurons from three independent experiments. There were 3.3 AE 0.2 LC3 puncta per neuron in control cultures and 7.7 AE 0.7 LC3 puncta per neuron in HNE-treated neurons (p < 0.0001) (Fig. 3b) . The numbers of p62 puncta were 6.6 AE 0.4 in control neurons and 16.9 AE 1.2 in HNEtreated neurons (p < 0.0001) (Fig. 3c) . To determine whether the increase of LC3II and p62 protein levels in HNE-treated neurons was a result of elevated gene expression, we performed real-time PCR to measure the levels of LC3 and p62 mRNAs. With Gapdh (glyceraldehyde-3-phosphate dehydrogenase) mRNA as an internal control, we found no decrease of LC3 and p62 in neurons ( Fig. 3d and  e) . Taken together, the results suggest that the increase of LC3II in HNE-treated neurons was a result of an inhibition on lysosomal degradation rather than an induction of macroautophagy flux.
Evidence that HNE inhibits lysosomes involved in chaperone-mediated autophagy
Compromised lysosome function should impair CMA. To evaluate this possibility, we measured relative levels of Hsc70 and LAMP2a, markers of CMA (Massey et al., 2006) , in control and HNE-treated neurons. The levels of LAMP2a and Hsc70 protein and mRNA were measured in neurons exposed to 5 lM HNE for increasing time periods. Levels of LAMP2a protein decreased progressively beginning within 4 h (72.5 AE 21.8%) and continuing through 8 h (55.3 AE 17.5%) and 24 h (40.2 AE 26.8%) in neurons exposed to HNE ( and b). Hsc70 protein levels were significantly reduced within 1 h of exposure to HNE and remained reduced through 24 h (87.9 AE 3.7%, 79.8 AE 5.8%, 82.9 AE 3.4%, 84.8 AE 5.3% and 74.9 AE 10.2% at 1, 2, 4, 8 and 24 h, respectively) ( Fig. 4a  and c) . Levels of Lamp2a mRNA and Hsc70 mRNA were not significantly affected by HNE treatment, although there was a trend toward reduced Hsc70 mRNA levels at the 8 and 24 h time points (Fig. 4d and e) .
HNE causes the accumulation of polyubiquitinated proteins in neurons
Previous findings suggest that compromised lysosome function is associated with an abnormal accumulation of polyubiquitinated proteins in vulnerable neuronal populations in AD and PD (Nixon 2013; McKinnon and Tabrizi 2014) . Impaired lysosomal function would be expected to result in the accumulation of ubiquitinated proteins in the neurons. We Fig. 3 4-hydroxynonenal (HNE) causes the accumulation of LC3-and p62-immunoreactive puncta in neurons without affecting LC3 and p62 mRNA levels. (a) Neurons exposed to ethanol (Con) or HNE for 6 h were fixed with 100% cold methanol for 15 min at À20°C, and then co-stained with anti-LC3 (green) and anti-p62 (red) antibodies. Nuclear DNA was stained with Hoechst (blue). Images were acquired using a 409 objective with Zeiss LSM 410 confocal microscope. Representative neurons (arrows) from each group are shown in high magnification images on the right. Scale bars: 50 lm in left panels and 10 lm in right panels. (b and c) Numbers of LC3-and p62-positive puncta per neuron were counted. Results were from analyses of 182 control neurons and 62 HNE-treated neurons in three independent experiments (n = 3). ***p < 0.001. (d and e) Levels of LC3 (d) and p62 (e) mRNAs were quantified using real-time PCR in RNA samples from neurons treated with ethanol or HNE for the indicated time periods.
therefore performed ubiquitin immunostaining in neurons exposed for 6 h to vehicle (control) or HNE. Although ubiquitin-containing puncta were sparse in the neurites of control neurons, they were abundant in the neurites of HNEtreated neurons (Fig. 5a ). We quantified numbers of ubiquitin immunoreactive puncta in the neurites of neurons and found that ubiquitin-containing puncta were 3-fold more abundant in HNE-treated neurons (168.2 AE 11.3%) compared to control neurons (60.6 AE 6.6%) ( Fig. 5b ; p < 0.001). The total amount of ubiquitin, including mono-and polyubiquitin, was increased by approximately 30% in neurons exposed to HNE for 6 h ( Fig. 5c and d) . Ubiquitinated proteins can be degraded in proteasomes and by autophagy. We used antibodies specific for either K48-linked polyubiquitin (K48-Ub, which is targeted to the proteasome) or K63-linked polyubiquitin (K63-Ub, which is targeted for lysosomal degradation) to distinguish undegraded substrates for the two different systems. Increased amounts of K48-Ub proteins were detected in HNE-treated neurons at 6 h ( Fig. 5e and f) , and more so at 24 h ( Fig. 5i and j) . Increased accumulation of K63-Ub proteins was not evident at 6 h ( Fig. 5g and h) but was evident at 24 h ( Fig. 5k and l) .
HNE inhibits lysosomal activity in neurons
As the data to this point suggested that impairment of lysosome function is an early event in HNE-induced neuronal degeneration, we performed a series of experiments in which we evaluated the effects of HNE on indicators of lysosome functionality. First, we employed the pH-sensitive lysosometargeted probe Lysosensor green to evaluate the relative pH of lysosomes in control and HNE-treated neurons. Cortical neurons treated with 100 lM bafilomycin A1 for 24 h exhibited a significant decrease of Lysosensor fluorescence intensity compared with control neurons, indicating an increase of the pH within the lysosomes (Fig. 6a and b) . A significant decrease in Lysosensor fluorescence was detected in HNE-treated neurons within 2 h of exposure and the fluorescence was further decreased at 24 h ( Fig. 6a and b) . We next evaluated the ability of lysosomes to degrade substrates using the probe DQ-BSA whose fluorescence increases after being hydrolyzed in lysosomes. HNE significantly inhibited DQ-BSA degradation in lysosomes of neurons at 6 h (29.24 AE 9.9% of the fluorescence level in control neurons), while 100 nM Bafilomycin A1 inhibited its degradation to 29.8 AE 4.5% (Fig. 6c) . Cathepsins B and D are two lysosomal enzymes that hydrolyze substrates. We measured the activities of cathepsins B and D with using commercially available kits. Levels of cathepsin D activity were not significantly reduced in neurons exposed to either HNE or bafilomycin A during a 6 h exposure period (Fig. 6d) . Intriguingly, the activity of cathepsin B was greatly reduced in HNE-neurons (41.8 AE 3.9% of control neurons) and in bafilomycin A-treated neurons (63.2 AE 6.4% of control neurons) (Fig. 6g) . To determine whether the protein levels of cathepsins were involved in the activity of cathepsins in HNE-treated neurons, we did a WB assay on cathepsin B and D at 6 h. Protein levels of mature cathepsin D were comparable in HNE-treated neurons, but showed a trend of increase in Baf-treated neurons ( Figure S1a and b). More interestingly, immunoblot analysis also showed that levels of pro-cathepsin D (which is generated in part by the activity of cathepsin B) were decreased in neurons exposed to HNE, but not in neurons exposed to bafilomycin A ( Fig. 6e  and f) . Levels of pro-cathepsin B protein were not changed in HNE-treated neurons ( Fig. 6h and i) , indicating that the reduction of cathepsin B activity levels was not the result of decreased levels of the enzyme. Together, these findings suggest that decreased activity of cathepsin B at an earlier time may results in decrease of active cathepsin D in neurons with longer exposure to HNE. Finally, to determine whether alterations macroautophagy and/or CMA upstream of lysosomes play a role in neuronal degeneration in response to HNE, we treated neurons with rapamycin to stimulate autophagy, wortmannin to inhibit autophagy upstream of lysosomes, or bafilomycin A1 to inhibit lysosomes, alone or in combination with HNE. Neuronal viability was evaluated using MTS reduction and LDH release assays. We found that inducing macroautophagy with rapamycin did not rescue the neurodegeneration caused by HNE (Fig. 6j and k) . Treatments with bafimolycin A1 or wortmannin enhanced HNE-induced neuronal death only modestly ( Fig. 6j and k) . These results are consistent with HNE acting primarily by inhibiting lysosome function.
Discussion
We found that a concentration of HNE within the range of concentrations present in the cerebrospinal fluid and brain tissue of AD patients (Lovell et al. 1997; Markesbery and Lovell 1998) impairs lysosome function in cerebral cortical neurons as indicated by decreased lysosomal pH, decreased hydrolysis of a substrate (DQ-BSA), and reduced activity of cathepsin B. This adverse effect of HNE on lysosomes is associated with the accumulation of autophagosomes and polyubquitinated proteins in the neurons, which occurs within 2-6 h and many hours to days before neurons die. Neurons exposed to HNE exhibited alterations in markers of macroautophagy (LC3 and p62) and CMA (LAMP2a and Hsc70) consistent with impairment of both pathways. The accumulation of polyubiquitinated proteins and autophagosomes in neurons in vulnerable brain regions are prominent features of many different neurodegenerative disorders including AD and PD (Nixon 2013; McKinnon and Tabrizi 2014) . It was previously reported that proteasomal proteins are modified by HNE in brain tissue samples from AD patients (Cecarini et al. 2007) , and that exposure of cultured motor neurons to HNE impairs proteasome activity (Keller et al. 2000a,b) . This is consistent with our finding that HNE results in increased aggregation of K48-linked polyubiquitinated proteins. Our findings that HNE impairs the degradation of K63-linked polyubiquitinated proteins and Neurons were treated for 6 h with 0.05% ethanol (Con) 5 lM HNE or 100 nM bafilomycin A (Baf) and then enzymatic activities (d and g) and protein levels (e, f, h and i) of cathepsins B and D were measured. Values are the mean and SEM of determinations made in three separate experiments. (j and k) Neurons were exposed to the indicated individual or combined treatments for 24 h and neuronal viability was evaluated by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (j) and lactate dehydrogenase (LDH) release (k) assays. HNE, 10 lM; Rap: 100 nM rapamycin; Baf, 100 nM bafilomycin A; WRT, 5 lM wortmannin. Values are the mean and SEM of determinations made in three independent experiments. Differences among groups were analyzed by Student's t-test. *p < 0.05, **p < 0.01, ***p < 0.001 compared to the control value or to the adjacent treatment condition as indicated.
lysosome function suggest a scenario in which membrane lipid peroxidation leads to impaired lysosome function and the accumulation of dysfunctional/damaged proteins in neurons.
Membrane lipid peroxidation is implicated in the pathogenesis of age-related neurodegenerative disorders, as well as in the neuronal dysfunction and death that results from acute CNS injuries such as stroke and traumatic brain injury Mattson 2009; Sultana et al. 2013) . HNE-modified proteins accumulate in association with neuronal degeneration in the brains of AD and PD patients (Sayre et al. 1997; Wataya et al. 2002) . Studies of experimental neuronal culture and animal models of AD have provided evidence that lipid peroxidation and HNE impair cellular ion homeostasis and mitochondrial function in neurons, thereby rendering the neurons vulnerable to excitotoxic and metabolic stress Mark et al. 1997a,b) . HNE may also promote amyloidogenic processing of the b-amyloid precursor protein, thereby accelerating the accumulation of Ab (Gwon et al. 2012) , and can also promote aggregation of Ab (Siegel et al. 2007 ). In the case of PD, HNE is present in abnormally high amounts in the substantia nigra (Yoritaka et al. 1996) . However, it is unclear if and how HNE may contribute to the intracellular accumulation of ubiquitinated, and disease-defining pathogenic proteins in AD (pTau and Ab) and PD (a-synuclein). Our findings suggest a potential role for HNE in an early impairment of lysosome function in the pathogenic accumulation of proteotoxic protein aggregates in neurons in proteopathic neurodegenerative disorders.
Accumulation of ubiquitinated proteins in neurons subjected to oxidative stress and HNE could result from impaired function and/or overload of the proteasomal or lysosomal degradation pathways. Numerous studies have shown that oxidative stress can impair proteasome function (Shang and Taylor 2011) , and it was also reported that HNE can impair proteasome function in cultured tumor cells and isolated proteasomes (Keller et al. 2000a,b; Ferrington and Kapphahn 2004) . Our findings suggest that HNE can also impair CMA and macroautophagy in primary cerebral cortical neurons. We found that the levels of LC3II increased in cortical neurons within 1 h of exposure to HNE, and accumulation of LC3 and p62 immunoreactive puncta in the cytoplasm within 6 h. It was previously reported that the suppression of macroautophagy by genetic deletion of Atg5 or Atg7 causes neurodegeneration in mice (Hara et al. 2006; Komatsu et al. 2006) . Interestingly, a brief 30 min exposure of cultured vascular smooth muscle cells to HNE caused a robust increase of LC3II levels and cellular vacuolization, formation of pinocytic bodies, crescent-shaped phagophores, and multilamellar vesicles (Hill et al. 2008) . The latter study further showed that the degradation of HNE-protein adducts could be increased with rapamycin, a well-known inducer of autophagy. We also found that the levels of LAMP2a and Hsc70 decreased in neurons within 4-6 h of exposure to HNE, consistent with an impaired ability of the neurons to recruit substrates to the lysosomes. Previous studies have shown that the levels of the CMA markers LAMP2Aand Hsc70, are significantly reduced in the substantia nigra pars compacta of PD patients compared to age-matched control subjects (Alvarez-Erviti et al. 2010) . It is not known whether HNE is involved in the impairment of CMA in PD.
The specific protein target(s) involved in lysosome function that are adversely affected by HNE modification remain to be determined. One possibility is that HNE impairs the function of the vacuolar ATPase in the lysosome membrane. Consistent with this, we found that adverse effects of HNE on mitochondrial function were not exacerbated by bafilomycin A, a known inhibitor of the vacuolar ATPase. HNE may also directly inhibit cathepsin B and other lysosomal cysteine proteases by covalently modifying the enzyme active site (Crabb et al. 2002; Krohne et al. 2010) . Moreover, modification of some protein substrates by HNE may render them unable to be degraded because of impaired ubiquitination, the inability of autophagic pathways to recognize or process the ubiquitinated proteins, or impaired proteolysis in the lysosome (Krohne et al. 2010 ). In the case of neurons, data indicate that Ab, Tau and a-synuclein can be modified on one or more residues Qahwash et al. 2007; Xiang et al. 2015) . It was reported that HNE modifies and inhibits the enzymatic activities of the lysosomal enzymes cathepsins B and L in retinal pigment epithelial cells (Krohne et al., 2010) . Modification of Hsc70 by HNE can increase the sensitivity of Hsc70 to calpainmediated proteolysis in hippocampal cells (Sahara and Yamashima 2010) . The latter findings are particularly interesting in light of the fact that calpains are Ca 2+ -dependent proteases, and that HNE can destabilize neuronal Ca 2+ regulation, resulting elevated levels of cytosolic Ca 2+ and vulnerability of neurons to excitotoxicity, a type of neuronal damage implicated in AD, PD, and other neurodegenerative disorders (Schulz 2007; Bezprozvanny and Mattson 2008) . Altogether, the emerging evidence suggests that disturbances in cellular redox homeostasis, energy metabolism, Ca 2+ handling, and lysosome function crossamplify each other in neurodegenerative disorders. Our findings suggest that HNE-mediated impairment of lysosomal function may contribute to such neurodegenerative cascades.
Early preclinical findings suggest a potential for targeting HNE as a neuroprotective intervention. One approach is to scavenge HNE with peptides or modified peptides to which HNE binds covalently. For example, glutathione, a tripeptide with a cysteine residue to which HNE binds, can protect neurons against damage and death induced by lipid peroxidation and HNE (Kruman et al. 1997; Mark et al. 1997a) . It was also reported that a novel histidine analog that scavenges HNE can protect neurons in cell culture and animal models of ischemic stroke (Tang et al. 2007 ). Another approach is to facilitate clearance of potentially pathogenic proteins by stimulating autophagy with drugs such as rapamycin (Bai et al. 2015) , or interventions such as intermittent fasting and exercise (Mattson 2012) . A better understanding of the events upstream of lipid peroxidation and generation of HNE, and of the mechanisms by which HNE impairs the ability of neurons to remove potentially toxic proteins, may lead to novel approaches for preventing and treating many different neurodegenerative conditions. All experiments were conducted in compliance with the ARRIVE guidelines
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Supporting information
Additional Supporting Information may be found online in the supporting information tab for this article: Figure S1 . (a) Cortical neurons were treated for 6 hours with 0.5% ethanol (control), 5 lM HNE or 100 nM bafilomycin. Proteins in cell lysates were subjected to immunoblot analysis using a cathepsin D antibody. Results of densitometric analysis of blots showing relative levels of mature cathepsin D in neurons treated for 6 hours with 0.5% ethanol (control), 5 lM HNE or 100 nM bafilomycin. There were no significant differences among these groups.
